FTC Acts Against Pharmacy Benefit Managers
In a significant development for the U.S. healthcare industry, the Federal Trade Commission has taken decisive action against the three largest Pharmacy Benefit Managers (PBMs), Caremark Rx, Express Scripts and OptumRx, for alleged anticompetitive practices that have artificially inflated insulin prices. This move comes on the heels of a comprehensive July 2024 Interim Staff Report … Read more